Akoya Biosciences News

Piper Sandler Keeps Their Buy Rating on Akoya Biosciences (AKYA)

TipRanksApr 9 07:06 ET

Akoya Biosciences (AKYA) Gets a Buy From Piper Sandler

TipRanksMar 12 06:36 ET

Akoya Biosciences Analyst Ratings

BenzingaMar 6 11:05 ET

Akoya Biosciences Analyst Ratings

BenzingaMar 5 08:56 ET

Akoya Biosciences (AKYA) Gets a Buy From BTIG

TipRanksJan 7 05:27 ET

BTIG Sticks to Its Buy Rating for Akoya Biosciences (AKYA)

TipRanksJan 2 09:10 ET

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Akoya Biosciences (AKYA)

TipRanksDec 21, 2023 08:40 ET

Akoya Biosciences Analyst Ratings

BenzingaDec 14, 2023 06:22 ET

Analysts Offer Insights on Healthcare Companies: Tenon Medical, Inc. (TNON), Akoya Biosciences (AKYA) and Bioxcel Therapeutics (BTAI)

TipRanksNov 16, 2023 08:00 ET

Analysts Offer Insights on Healthcare Companies: HilleVax, Inc (HLVX), Akoya Biosciences (AKYA) and Clinigence Holdings (NUTX)

TipRanksNov 14, 2023 07:20 ET

Piper Sandler Maintains Overweight on Akoya Biosciences, Lowers Price Target to $8

BenzingaNov 13, 2023 16:09 ET

Akoya Biosciences Analyst Ratings

BenzingaNov 13, 2023 16:08 ET

Stephens & Co. Maintains Overweight on Akoya Biosciences, Lowers Price Target to $9

BenzingaNov 13, 2023 09:13 ET

Akoya Biosciences Analyst Ratings

BenzingaNov 13, 2023 09:12 ET

Akoya Biosciences (AKYA) Receives a Buy From Piper Sandler

TipRanksNov 9, 2023 12:23 ET

Analysts Offer Insights on Healthcare Companies: Akoya Biosciences (AKYA), Paycor HCM (PYCR) and ADC Therapeutics (ADCT)

TipRanksNov 9, 2023 05:51 ET

Morgan Stanley Maintains Overweight on Akoya Biosciences, Lowers Price Target to $8

BenzingaOct 24, 2023 08:20 ET

Akoya Biosciences Analyst Ratings

BenzingaOct 24, 2023 08:20 ET

Piper Sandler Maintains Overweight on Akoya Biosciences, Lowers Price Target to $11

BenzingaOct 16, 2023 13:18 ET

Akoya Biosciences Analyst Ratings

BenzingaOct 16, 2023 13:17 ET